← Back to graph

Prescription

eladocagene exuparvovec AADC deficiency Upstaza

Selected indexed studies

Eladocagene Exuparvovec: First Approval. (Drugs, 2022) [PMID:36103022]
Gene Therapy for Dopamine Dyshomeostasis: From Parkinson's to Primary Neurotransmitter Diseases. (Mov Disord, 2023) [PMID:37147851]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Eladocagene Exuparvovec: First Approval. (2022) pubmed
Gene Therapy for Dopamine Dyshomeostasis: From Parkinson's to Primary Neurotransmitter Diseases. (2023) pubmed

Local graph